The medication works by mimicking the incretin hormone GLP-1, which enhances insulin secretion, suppresses glucagon release, slows gastric emptying (though this effect may attenuate over time), and reduces appetite through central nervous system pathways
Ipamorelin, with its selective GH release, helps increase fat utilization without elevating cortisol levels
Disease-Modifying Antirheumatic Drugs (DMARDs): Such as methotrexate or sulfasalazine, to slow disease progression and protect joints
In fact, Semaglutide was found to reduce weight by 17% when taken as recommended
Clinical trials show an average weight loss of 15-20% over 68 weeks
Iron overload-induced ROS generation, similar to p53 acetylation, also promotes M1 polarization (98, 99)